The global disease-modifying antirheumatic drug (DMARD) market is estimated to be valued at US$ 20,671.1 million in 2022 and is expected to exhibit a CAGR of 3.5% during the forecast period (2022-2030).
Figure 1.Global Disease-Modifying Antirheumatic Drug (DMARD) Market Share (%) in Terms of Value, By Drug Type, 2022
Increasing prevalence of rheumatoid arthritis disease is expected to drive the market growth during the forecast period.
Increasing prevalence of rheumatoid arthritis disease which is expected to drive the global disease-modifying antirheumatic drug (DMARD) market growth over the forecast period. For instance, according to data published by National Center for Biotechnology Information in June 2022, stated that the annual incidence of RA (Rheumatoid Arthritis) in the U.S. and other western nations of northern Europe is about 40 per 100,000 persons.
Disease-Modifying Antirheumatic Drug (DMARD) Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients